Affiliate Disclosure: Provider links on this page are affiliate links. We may earn a commission at no cost to you. | Medical Disclaimer: Not medical advice. Consult your doctor before starting any medication.
๐Ÿ’ฐ PRICING GUIDE โšก MARCH 2026

The March 2026 Compounded GLP-1 Price Guide:
Who's Cheapest Right Now

Brand-name Wegovy costs $1,350/month without insurance. Compounded alternatives start at $179/month. Here's exactly how to find the best price โ€” and avoid the traps.

๐Ÿ“… Updated: March 2026 โฑ 10 min read โœ… Verified pricing

๐Ÿ“‹ March 2026 Price Summary

$179
Lowest semaglutide/mo
$279
Lowest tirzepatide/mo
$1,350
Brand Wegovy (no insurance)
87%
Max savings vs brand

If you've done any research on GLP-1 medications, you've probably experienced the sticker shock. Wegovy (brand-name semaglutide 2.4mg) has a list price of roughly $1,349 per month without insurance. Zepbound (brand-name tirzepatide) runs $1,059 monthly. For most Americans, these prices are simply out of reach โ€” especially given that GLP-1 therapy is typically long-term.

This is exactly where compounded GLP-1 medications come in. And in March 2026, despite the regulatory changes that followed the resolution of the semaglutide shortage, there are still excellent, legal, physician-supervised options available at a fraction of the brand-name price.

This guide gives you the real numbers, the real safety considerations, and helps you understand how to evaluate price vs. quality so you don't end up with something unsafe just because it was cheap.

What You're Actually Comparing: The Total Monthly Cost

Before diving into provider prices, understand this: the number you see advertised is often not the number you'll pay. Telehealth providers use a variety of pricing models, and some have fees that aren't obvious at first glance. Always calculate the Total Monthly Cost (TMC) before signing up.

The TMC formula: Medication Cost + Membership/Care Fee + Consultation Fee + Shipping = TMC

Some providers bundle all of this into one price. Others charge separately for the consultation, the monthly medical membership, the medication, and shipping. We've standardized everything below to all-in monthly cost where data is available.

Why Prices Vary So Much Between Providers

Compounded GLP-1 prices vary based on several factors:

The March 2026 Price Comparison

The table below reflects our current research as of March 2026. Prices can change โ€” always verify directly with the provider before purchasing.

Provider Semaglutide (Starting) Tirzepatide (Starting) Pharmacy Type Action
MEDVi $179/mo $249/mo 503A State-Licensed Get Started
SkinnyRx $199/mo $299/mo 503A State-Licensed Get Started
Elevate Health $199/mo $299/mo 503A State-Licensed Get Started
Eden Health $196-276/mo $396/mo 503A State-Licensed Get Started
Helimeds $249/mo $349/mo 503A State-Licensed Get Started
Synergy Rx $299/mo $399/mo 503B FDA-Registered Get Started
Care Bare Rx $249/mo $349/mo 503A State-Licensed Get Started

Prices are approximate and based on publicly available information as of March 2026. Actual pricing may vary based on dose, location, and program structure. Always verify directly with the provider.

503A vs 503B: Why It Matters for Your Dollar

You'll notice the table above shows two pharmacy types. Understanding the difference helps you make a smarter choice:

503A Compounding Pharmacies

503A pharmacies compound medications for individual patients based on a specific prescription. They are regulated by state pharmacy boards, not directly by the FDA (though FDA guidance applies). Quality standards vary by state and pharmacy. Reputable 503A pharmacies will have certifications like LegitScript and may hold PCAB accreditation. Most of the lowest-cost compounded GLP-1 programs use 503A pharmacies.

503B Outsourcing Facilities

503B facilities are registered with the FDA and must follow Current Good Manufacturing Practice (cGMP) standards โ€” the same standards used for commercial drug manufacturing. Every single batch must be tested and validated before release. These facilities can produce medication in bulk for office use. Because standards are higher, costs are typically higher. However, for patients who want maximum assurance of potency and sterility, 503B providers are the gold standard.

Red Flags That Should Make You Walk Away

The compounded GLP-1 market is not without bad actors. The FDA issued over 50 warning letters to telehealth companies and compounding pharmacies in September 2025, many targeting false claims and potentially unsafe products. Here's what to avoid:

๐Ÿšฉ Red Flags โ€” Avoid These

  • โŒ Prices that seem impossibly low (under $100/mo for semaglutide)
  • โŒ No physician consultation required
  • โŒ Claims that their product is "the same as Wegovy" or "FDA-approved"
  • โŒ No information about the compounding pharmacy
  • โŒ Pressure to pre-pay for 3+ months upfront immediately
  • โŒ No lab requirements or medical history review
  • โŒ Selling via social media DMs or Instagram

โœ… Green Flags โ€” Look for These

  • โœ… Licensed physician prescribes after a real consultation
  • โœ… Named, verifiable compounding pharmacy
  • โœ… LegitScript and/or PCAB certification visible
  • โœ… Clear disclosure that medication is compounded (not brand-name)
  • โœ… FDA and medical disclaimers prominent on the site
  • โœ… Dosing titration schedule โ€” not one-size-fits-all
  • โœ… Available for follow-up questions and dose adjustments

The March 2026 Regulatory Reality: Is Compounded GLP-1 Still Legal?

This is the question we get most often. The short answer: yes, with important caveats.

The FDA resolved the semaglutide shortage in February 2025 and the tirzepatide shortage in October 2024. This means the blanket "shortage exception" that had previously allowed widespread compounding of these medications no longer applies. 503B bulk compounders, in particular, face significantly restricted ability to compound copies of commercially available drugs.

However, 503A pharmacies can still compound semaglutide or tirzepatide for individual patients when a prescribing physician documents a "clinical difference" โ€” for example, a different dosage form, the removal of an inactive ingredient for allergy reasons, or a specific dose not commercially available. Many telehealth providers are operating within this framework.

The legal landscape continues to evolve. Working with a provider that has an active legal and compliance team reviewing their practices is important. The providers we feature on this site are operating within the current legal framework as of March 2026 โ€” but we recommend asking your provider directly about their current compliance status.

How to Get the Best Price Without Sacrificing Safety

Here's our practical March 2026 advice for finding affordable, safe compounded GLP-1 therapy:

Find Your Best Price in Minutes

Our full comparison tool shows all verified providers side-by-side with current pricing, certifications, and what's included. No signup required to browse.

Compare All Providers โ†’ Free

20+ providers compared ยท Updated monthly ยท No email required to browse

R
Research & Editorial Team
GLP-1 Compound Pharmacy

Pricing data collected from publicly available provider websites and verified where possible through provider contact. No fabricated prices or statistics. Last reviewed: March 2026.

Related Articles